Auxellence Announces Private Placement

Auxellence Health Corporation

Healthcare & Pharmaceutical

Share Tweet

Auxellence Announces Private Placement

VANCOUVER, BC / ACCESSWIRE / April 21, 2014 / Auxellence Health Corporation (CSE:AID) (the "Company" or "Auxellence") today announced that it intends to raise gross proceeds of up to CDN $100,000 through a non-brokered private placement of common shares or convertible debt convertible into shares of the Company (the "Shares") at a price of 15 cents per common share (the "Offering"). A finder's fee of up to 8% cash may be paid on portions of the gross proceeds.

Proceeds from the Offering are intended to be used as working capital to support commercialization of the Company's services, with emphasis on weight management and skin health (acne) conditions and for general corporate purposes. The Shares or Convertible Debt to be issued in connection with this Offering will be subject to a four month hold period from the share issuance date in accordance with the policies of the Canadian Securities Exchange (CSE) and applicable securities laws. The Offering is subject to all necessary regulatory and stock exchange approvals.


Sydney Au, President & CEO

Auxellence Health Corporation

Email: [email protected]

Phone: (604) 780-3311

About Auxellence Health Corporation

Auxellence is a health technology company that aims to provide high-level online personal health services to consumers, providers and suppliers of OTC (Over-The-Counter) health care products and services, including refining the effectiveness of prescribing services to the OTC (Over-The-Counter) consumer pharmaceutical and natural health industry. The Company is integrating innovative therapeutic and diagnostic (theragnostic) devices (hardware components), along with an interactive Expert System and Recommender "PRESCRIPTOR" engine (software platform) to acquire physiological data for personalized medicine and health solutions to everyday health issues (initially targeting weight management and skin health conditions (acne)).

Disclaimer for Forward-Looking Information Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. Except as required by law, the Company does not intend to update any changes to such statements. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.



SOURCE: Auxellence Health Corporation